WASHINGTON (AP) — U.S. applications for unemployment benefits inched down modestly last week, remaining at historically healthy levels despite recent…
Read More
Lynx1 Master Fund Critiques Neuphoria Therapeutics Inc. Board’s Capital-Raising Strategy and Proposes Indepfinishent Director Nominees in Proxy Statement
On December 2, 2025, Lynx1 Master Fund LP announced that on November 24, 2025, Lynx1 and its affiliates filed a…
Read More
